Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Apr;144(4):637–650.

Modulation of major histocompatibility complex antigen expression by viral infection.

C R Rinaldo Jr 1
PMCID: PMC1887252  PMID: 8160765

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson M. L., Stam N. J., Klein G., Ploegh H. L., Masucci M. G. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. Int J Cancer. 1991 Feb 20;47(4):544–550. doi: 10.1002/ijc.2910470412. [DOI] [PubMed] [Google Scholar]
  2. Andersson M., McMichael A., Peterson P. A. Reduced allorecognition of adenovirus-2 infected cells. J Immunol. 1987 Jun 1;138(11):3960–3966. [PubMed] [Google Scholar]
  3. Andersson M., Päbo S., Nilsson T., Peterson P. A. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell. 1985 Nov;43(1):215–222. doi: 10.1016/0092-8674(85)90026-1. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. D., Grundy J. E. Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol. 1992 Sep;73(Pt 9):2395–2403. doi: 10.1099/0022-1317-73-9-2395. [DOI] [PubMed] [Google Scholar]
  5. Beck S., Barrell B. G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature. 1988 Jan 21;331(6153):269–272. doi: 10.1038/331269a0. [DOI] [PubMed] [Google Scholar]
  6. Beersma M. F., Bijlmakers M. J., Ploegh H. L. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol. 1993 Nov 1;151(9):4455–4464. [PubMed] [Google Scholar]
  7. Beersma M. F., Wertheim-van Dillen P. M., Geelen J. L., Feltkamp T. E. Expression of HLA class I heavy chains and beta 2-microglobulin does not affect human cytomegalovirus infectivity. J Gen Virol. 1991 Nov;72(Pt 11):2757–2764. doi: 10.1099/0022-1317-72-11-2757. [DOI] [PubMed] [Google Scholar]
  8. Billingham M. E. Cardiac transplant atherosclerosis. Transplant Proc. 1987 Aug;19(4 Suppl 5):19–25. [PubMed] [Google Scholar]
  9. Bluestone J. A., Kaliyaperumal A., Jameson S., Miller S., Dick R., 2nd Peptide-induced changes in class I heavy chains alter allorecognition. J Immunol. 1993 Oct 15;151(8):3943–3953. [PubMed] [Google Scholar]
  10. Boldogh I., AbuBakar S., Albrecht T. Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. Science. 1990 Feb 2;247(4942):561–564. doi: 10.1126/science.1689075. [DOI] [PubMed] [Google Scholar]
  11. Boldogh I., AbuBakar S., Deng C. Z., Albrecht T. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J Virol. 1991 Mar;65(3):1568–1571. doi: 10.1128/jvi.65.3.1568-1571.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Borysiewicz L. K., Graham S., Hickling J. K., Mason P. D., Sissons J. G. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur J Immunol. 1988 Feb;18(2):269–275. doi: 10.1002/eji.1830180214. [DOI] [PubMed] [Google Scholar]
  13. Boshkov L. K., Macen J. L., McFadden G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J Immunol. 1992 Feb 1;148(3):881–887. [PubMed] [Google Scholar]
  14. Browne H., Churcher M., Minson T. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J Virol. 1992 Nov;66(11):6784–6787. doi: 10.1128/jvi.66.11.6784-6787.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Browne H., Smith G., Beck S., Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature. 1990 Oct 25;347(6295):770–772. doi: 10.1038/347770a0. [DOI] [PubMed] [Google Scholar]
  16. Bruggeman C. A., Debie W. H., Muller A. D., Schutte B., van Dam-Mieras M. C. Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb Haemost. 1988 Apr 8;59(2):264–268. [PubMed] [Google Scholar]
  17. Buchmeier N. A., Cooper N. R. Suppression of monocyte functions by human cytomegalovirus. Immunology. 1989 Feb;66(2):278–283. [PMC free article] [PubMed] [Google Scholar]
  18. Burgert H. G., Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell. 1985 Jul;41(3):987–997. doi: 10.1016/s0092-8674(85)80079-9. [DOI] [PubMed] [Google Scholar]
  19. Burgert H. G., Maryanski J. L., Kvist S. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1356–1360. doi: 10.1073/pnas.84.5.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Burns L. J., Waring J. F., Reuter J. J., Stinski M. F., Ginder G. D. Only the HLA class I gene minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genes. Blood. 1993 Mar 15;81(6):1558–1566. [PubMed] [Google Scholar]
  21. Campbell A. E., Slater J. S., Cavanaugh V. J., Stenberg R. M. An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes. J Virol. 1992 May;66(5):3011–3017. doi: 10.1128/jvi.66.5.3011-3017.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Campbell I. L., Harrison L. C. Viruses and cytokines: evidence for multiple roles in pancreatic beta cell destruction in type 1 insulin-dependent diabetes mellitus. J Cell Biochem. 1989 May;40(1):57–66. doi: 10.1002/jcb.240400107. [DOI] [PubMed] [Google Scholar]
  23. Christinck E. R., Luscher M. A., Barber B. H., Williams D. B. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature. 1991 Jul 4;352(6330):67–70. doi: 10.1038/352067a0. [DOI] [PubMed] [Google Scholar]
  24. Colberg-Poley A. M., Santomenna L. D., Harlow P. P., Benfield P. A., Tenney D. J. Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J Virol. 1992 Jan;66(1):95–105. doi: 10.1128/jvi.66.1.95-105.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Colberg-Poley A. M., Santomenna L. D. Selective induction of chromosomal gene expression by human cytomegalovirus. Virology. 1988 Sep;166(1):217–228. doi: 10.1016/0042-6822(88)90163-8. [DOI] [PubMed] [Google Scholar]
  26. Cordiali P., Balzarotti V., Morante S., Parisi V., Pugliese O., Camponeschi B., Colizzi V. Convergent evolution in the homology between HIV gp160 and HLA class II molecules. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1561–1565. doi: 10.1089/aid.1992.8.1561. [DOI] [PubMed] [Google Scholar]
  27. David-Watine B., Israël A., Kourilsky P. The regulation and expression of MHC class I genes. Immunol Today. 1990 Aug;11(8):286–292. doi: 10.1016/0167-5699(90)90114-o. [DOI] [PubMed] [Google Scholar]
  28. Del Val M., Münch K., Reddehase M. J., Koszinowski U. H. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell. 1989 Jul 28;58(2):305–315. doi: 10.1016/0092-8674(89)90845-3. [DOI] [PubMed] [Google Scholar]
  29. Dhib-Jalbut S. S., Cowan E. P. Direct evidence that interferon-beta mediates enhanced HLA-class I expression in measles virus-infected cells. J Immunol. 1993 Dec 1;151(11):6248–6258. [PubMed] [Google Scholar]
  30. Doherty P. C., Allan W., Eichelberger M., Carding S. R. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol. 1992;10:123–151. doi: 10.1146/annurev.iy.10.040192.001011. [DOI] [PubMed] [Google Scholar]
  31. Doherty P. C. Virus infections in mice with targeted gene disruptions. Curr Opin Immunol. 1993 Aug;5(4):479–483. doi: 10.1016/0952-7915(93)90026-o. [DOI] [PubMed] [Google Scholar]
  32. Duncombe A. S., Grundy J. E., Oblakowski P., Prentice H. G., Gottlieb D. J., Roy D. M., Reittie J. E., Bello-Fernandez C., Hoffbrand A. V., Brenner M. K. Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1). Blood. 1992 Jun 1;79(11):3059–3066. [PubMed] [Google Scholar]
  33. Eager K. B., Pfizenmaier K., Ricciardi R. P. Modulation of major histocompatibility complex (MHC) class I genes in adenovirus 12 transformed cells: interferon-gamma increases class I expression by a mechanism that circumvents E1A induced-repression and tumor necrosis factor enhances the effect of interferon-gamma. Oncogene. 1989 Jan;4(1):39–44. [PubMed] [Google Scholar]
  34. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol. 1993 Jan;67(1):277–287. doi: 10.1128/jvi.67.1.277-287.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Faller D. V., Wilson L. D., Flyer D. C. Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus. J Cell Biochem. 1988 Mar;36(3):297–309. doi: 10.1002/jcb.240360310. [DOI] [PubMed] [Google Scholar]
  36. Finn O. J. Antigen-specific, MHC-unrestricted T cells. Biotherapy. 1992;4(4):239–249. doi: 10.1007/BF02172653. [DOI] [PubMed] [Google Scholar]
  37. Flyer D. C., Burakoff S. J., Faller D. V. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol. 1985 Oct;135(4):2287–2292. [PubMed] [Google Scholar]
  38. Fujinami R. S., Nelson J. A., Walker L., Oldstone M. B. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol. 1988 Jan;62(1):100–105. doi: 10.1128/jvi.62.1.100-105.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gardner I. D., Bowern N. A., Blanden R. V. Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex. Eur J Immunol. 1975 Feb;5(2):122–127. doi: 10.1002/eji.1830050210. [DOI] [PubMed] [Google Scholar]
  40. Gaulton G. N., Stein M. E., Safko B., Stadecker M. J. Direct induction of Ia antigen on murine thyroid-derived epithelial cells by reovirus. J Immunol. 1989 Jun 1;142(11):3821–3825. [PubMed] [Google Scholar]
  41. Gehrz R. C., Fuad S., Liu Y. N., Bach F. H. HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction. J Immunol. 1987 May 15;138(10):3145–3151. [PubMed] [Google Scholar]
  42. Gehrz R. C., Liu Y. N., Eckhardt J., Klaus A. Relevance of immune responses to pathogenesis of cytomegalovirus-associated diseases. Transplant Proc. 1991 Jun;23(3 Suppl 3):75–84. [PubMed] [Google Scholar]
  43. Georgopoulos C., McFarland H. Heat shock proteins in multiple sclerosis and other autoimmune diseases. Immunol Today. 1993 Aug;14(8):373–375. doi: 10.1016/0167-5699(93)90135-8. [DOI] [PubMed] [Google Scholar]
  44. Gerna G., Zipeto D., Percivalle E., Parea M., Revello M. G., Maccario R., Peri G., Milanesi G. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis. 1992 Dec;166(6):1236–1244. doi: 10.1093/infdis/166.6.1236. [DOI] [PubMed] [Google Scholar]
  45. Gilbert M. J., Riddell S. R., Li C. R., Greenberg P. D. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J Virol. 1993 Jun;67(6):3461–3469. doi: 10.1128/jvi.67.6.3461-3469.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Glimcher L. H., Kara C. J. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol. 1992;10:13–49. doi: 10.1146/annurev.iy.10.040192.000305. [DOI] [PubMed] [Google Scholar]
  47. Gogusev J., Teutsch B., Morin M. T., Mongiat F., Haguenau F., Suskind G., Rabotti G. F. Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts. Proc Natl Acad Sci U S A. 1988 Jan;85(1):203–207. doi: 10.1073/pnas.85.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Golding H., Robey F. A., Gates F. T., 3rd, Linder W., Beining P. R., Hoffman T., Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med. 1988 Mar 1;167(3):914–923. doi: 10.1084/jem.167.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Golding H., Shearer G. M., Hillman K., Lucas P., Manischewitz J., Zajac R. A., Clerici M., Gress R. E., Boswell R. N., Golding B. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest. 1989 Apr;83(4):1430–1435. doi: 10.1172/JCI114034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Gooding L. R. Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk. J Immunol. 1982 Sep;129(3):1306–1312. [PubMed] [Google Scholar]
  51. Gooding L. R. Virus proteins that counteract host immune defenses. Cell. 1992 Oct 2;71(1):5–7. doi: 10.1016/0092-8674(92)90259-f. [DOI] [PubMed] [Google Scholar]
  52. Grassi F., Meneveri R., Gullberg M., Lopalco L., Rossi G. B., Lanza P., De Santis C., Brattsand G., Buttò S., Ginelli E. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J Exp Med. 1991 Jul 1;174(1):53–62. doi: 10.1084/jem.174.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Grattan M. T., Moreno-Cabral C. E., Starnes V. A., Oyer P. E., Stinson E. B., Shumway N. E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989 Jun 23;261(24):3561–3566. [PubMed] [Google Scholar]
  54. Gregory C. D., Murray R. J., Edwards C. F., Rickinson A. B. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med. 1988 Jun 1;167(6):1811–1824. doi: 10.1084/jem.167.6.1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Grundy J. E., Ayles H. M., McKeating J. A., Butcher R. G., Griffiths P. D., Poulter L. W. Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection. J Med Virol. 1988 Aug;25(4):483–495. doi: 10.1002/jmv.1890250412. [DOI] [PubMed] [Google Scholar]
  56. Grundy J. E., Downes K. L. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology. 1993 Mar;78(3):405–412. [PMC free article] [PubMed] [Google Scholar]
  57. Grundy J. E., McKeating J. A., Griffiths P. D. Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. J Gen Virol. 1987 Mar;68(Pt 3):777–784. doi: 10.1099/0022-1317-68-3-777. [DOI] [PubMed] [Google Scholar]
  58. Grundy J. E., McKeating J. A., Sanderson A. R., Griffiths P. D. Cytomegalovirus and beta 2 microglobulin in urine specimens. Reciprocal interference in their detection is responsible for artifactually high levels of urinary beta 2 microglobulin in infected transplant recipients. Transplantation. 1988 Jun;45(6):1075–1079. [PubMed] [Google Scholar]
  59. Grundy J. E., McKeating J. A., Ward P. J., Sanderson A. R., Griffiths P. D. Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol. 1987 Mar;68(Pt 3):793–803. doi: 10.1099/0022-1317-68-3-793. [DOI] [PubMed] [Google Scholar]
  60. Grundy J. E., Pahal G. S., Akbar A. N. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody. Immunology. 1993 Mar;78(3):413–420. [PMC free article] [PubMed] [Google Scholar]
  61. Hattersley A. T., Lo Y. M., Read S. J., Eglin R. P., Wainscoat J. S., Clark A. Failure to detect cytomegalovirus DNA in pancreas in type 2 diabetes. Lancet. 1992 Feb 22;339(8791):459–460. doi: 10.1016/0140-6736(92)91062-d. [DOI] [PubMed] [Google Scholar]
  62. Hecht T. T., Summers D. F. Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells. J Virol. 1972 Oct;10(4):578–585. doi: 10.1128/jvi.10.4.578-585.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Hengel H., Lucin P., Jonjić S., Ruppert T., Koszinowski U. H. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol. 1994 Jan;68(1):289–297. doi: 10.1128/jvi.68.1.289-297.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Hermiston T. W., Tripp R. A., Sparer T., Gooding L. R., Wold W. S. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J Virol. 1993 Sep;67(9):5289–5298. doi: 10.1128/jvi.67.9.5289-5298.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Hosenpud J. D., Chou S. W., Wagner C. R. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation. 1991 Nov;52(5):896–903. doi: 10.1097/00007890-199111000-00027. [DOI] [PubMed] [Google Scholar]
  66. Howcroft T. K., Strebel K., Martin M. A., Singer D. S. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science. 1993 May 28;260(5112):1320–1322. doi: 10.1126/science.8493575. [DOI] [PubMed] [Google Scholar]
  67. Hu K. Q., Vierling J. M., Siddiqui A. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7140–7144. doi: 10.1073/pnas.87.18.7140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Jennings S. R., Rice P. L., Kloszewski E. D., Anderson R. W., Thompson D. L., Tevethia S. S. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol. 1985 Dec;56(3):757–766. doi: 10.1128/jvi.56.3.757-766.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Jilg W., Voltz R., Markert-Hahn C., Mairhofer H., Münz I., Wolf H. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells. Cancer Res. 1991 Jan 1;51(1):27–32. [PubMed] [Google Scholar]
  70. Joly E., Mucke L., Oldstone M. B. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 1991 Sep 13;253(5025):1283–1285. doi: 10.1126/science.1891717. [DOI] [PubMed] [Google Scholar]
  71. Joseph J., Knobler R. L., Lublin F. D., Hart M. N. Differential modulation of MHC class I antigen expression on mouse brain endothelial cells by MHV-4 infection. J Neuroimmunol. 1989 May;22(3):241–253. doi: 10.1016/0165-5728(89)90022-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Joseph J., Knobler R. L., Lublin F. D., Hart M. N. Mouse hepatitis virus (MHV-4, JHM) blocks gamma-interferon-induced major histocompatibility complex class II antigen expression on murine cerebral endothelial cells. J Neuroimmunol. 1991 Sep;33(3):181–190. doi: 10.1016/0165-5728(91)90105-G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Kannagi M., Kiyotaki M., King N. W., Lord C. I., Letvin N. L. Simian immunodeficiency virus induces expression of class II major histocompatibility complex structures on infected target cells in vitro. J Virol. 1987 May;61(5):1421–1426. doi: 10.1128/jvi.61.5.1421-1426.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Kerkau T., Gernert S., Kneitz C., Schimpl A. Mechanism of MHC class I downregulation in HIV infected cells. Immunobiology. 1992 Apr;184(4-5):402–409. doi: 10.1016/S0171-2985(11)80597-8. [DOI] [PubMed] [Google Scholar]
  75. Kerkau T., Schmitt-Landgraf R., Schimpl A., Wecker E. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res Hum Retroviruses. 1989 Dec;5(6):613–620. doi: 10.1089/aid.1989.5.613. [DOI] [PubMed] [Google Scholar]
  76. Khoury E. L., Pereira L., Greenspan F. S. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction. Am J Pathol. 1991 May;138(5):1209–1223. [PMC free article] [PubMed] [Google Scholar]
  77. Kraus E., Schneider-Schaulies S., Miyasaka M., Tamatani T., Sedgwick J. Augmentation of major histocompatibility complex class I and ICAM-1 expression on glial cells following measles virus infection: evidence for the role of type-1 interferon. Eur J Immunol. 1992 Jan;22(1):175–182. doi: 10.1002/eji.1830220126. [DOI] [PubMed] [Google Scholar]
  78. Kvist S., Ostberg L., Persson H., Philipson L., Peterson P. A. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5674–5678. doi: 10.1073/pnas.75.11.5674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Lapierre L. A., Fiers W., Pober J. S. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons. J Exp Med. 1988 Mar 1;167(3):794–804. doi: 10.1084/jem.167.3.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Lavi E., Suzumura A., Murray E. M., Silberberg D. H., Weiss S. R. Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. J Neuroimmunol. 1989 Apr;22(2):107–111. doi: 10.1016/0165-5728(89)90040-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Lehmann P. V., Sercarz E. E., Forsthuber T., Dayan C. M., Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today. 1993 May;14(5):203–208. doi: 10.1016/0167-5699(93)90163-F. [DOI] [PubMed] [Google Scholar]
  82. Lemström K. B., Bruning J. H., Bruggeman C. A., Lautenschlager I. T., Häyry P. J. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest. 1993 Aug;92(2):549–558. doi: 10.1172/JCI116622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Leopardi R., Ilonen J., Mattila L., Salmi A. A. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes. Cell Immunol. 1993 Apr 1;147(2):388–396. doi: 10.1006/cimm.1993.1078. [DOI] [PubMed] [Google Scholar]
  84. Lewis D. E., Ulrich R. G., Atassi H., Atassi M. Z. HLA-DR peptide inhibits HIV-induced syncytia. Immunol Lett. 1990 May;24(2):127–131. doi: 10.1016/0165-2478(90)90023-j. [DOI] [PubMed] [Google Scholar]
  85. Lindsley M. D., Patick A. K., Prayoonwiwat N., Rodriguez M. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc. 1992 Sep;67(9):829–838. doi: 10.1016/s0025-6196(12)60820-9. [DOI] [PubMed] [Google Scholar]
  86. Lindsley M. D., Torpey D. J., 3rd, Rinaldo C. R., Jr HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. J Immunol. 1986 Apr 15;136(8):3045–3051. [PubMed] [Google Scholar]
  87. Liu Y., King N., Kesson A., Blanden R. V., Müllbacher A. Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro. J Neuroimmunol. 1989 Feb;21(2-3):157–168. doi: 10.1016/0165-5728(89)90171-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Lopalco L., De Santis C., Meneveri R., Longhi R., Ginelli E., Grassi F., Siccardi A. G., Beretta A. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain. Eur J Immunol. 1993 Aug;23(8):2016–2021. doi: 10.1002/eji.1830230844. [DOI] [PubMed] [Google Scholar]
  89. Löhr J. M., Oldstone M. B. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet. 1990 Sep 15;336(8716):644–648. doi: 10.1016/0140-6736(90)92145-8. [DOI] [PubMed] [Google Scholar]
  90. Löhr M., Bergstrome B., Maekawa R., Oldstone M. B., Klöppel G. Human cytomegalovirus in the pancreas of patients with type 2 diabetes: is there a relation to clinical features, mRNA and protein expression of insulin, somatostatin, and MHC class II? Virchows Arch A Pathol Anat Histopathol. 1992;421(5):371–378. doi: 10.1007/BF01606908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Massa P. T., Dörries R., ter Meulen V. Viral particles induce Ia antigen expression on astrocytes. Nature. 1986 Apr 10;320(6062):543–546. doi: 10.1038/320543a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Massa P. T., Schimpl A., Wecker E., ter Meulen V. Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7242–7245. doi: 10.1073/pnas.84.20.7242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Masucci M. G., Stam N. J., Torsteinsdottir S., Neefjes J. J., Klein G., Ploegh H. L. Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines. Cell Immunol. 1989 May;120(2):396–400. doi: 10.1016/0008-8749(89)90207-4. [DOI] [PubMed] [Google Scholar]
  94. Masucci M. G., Torsteindottir S., Colombani J., Brautbar C., Klein E., Klein G. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4567–4571. doi: 10.1073/pnas.84.13.4567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Masucci M. G., Zhang Q. J., Gavioli R., De Campos-Lima P. O., Murray R. J., Brooks J., Griffin H., Ploegh H., Rickinson A. B. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Int Immunol. 1992 Nov;4(11):1283–1292. doi: 10.1093/intimm/4.11.1283. [DOI] [PubMed] [Google Scholar]
  96. Maudsley D. J., Bateman W. J., Morris A. G. Reduced stimulation of helper T cells by Ki-ras transformed cells. Immunology. 1991 Feb;72(2):277–281. [PMC free article] [PubMed] [Google Scholar]
  97. Maudsley D. J., Morris A. G. Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line. J Exp Med. 1988 Feb 1;167(2):706–711. doi: 10.1084/jem.167.2.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Maudsley D. J., Morris A. G. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. I. Effects on class I antigen expression. Immunology. 1989 May;67(1):21–25. [PMC free article] [PubMed] [Google Scholar]
  99. Maudsley D. J., Morris A. G. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. II. Effects on class II antigen expression. Immunology. 1989 May;67(1):26–31. [PMC free article] [PubMed] [Google Scholar]
  100. Mañez R., White L. T., Linden P., Kusne S., Martin M., Kramer D., Demetris A. J., Van Thiel D. H., Starzl T. E., Duquesnoy R. J. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation. 1993 May;55(5):1067–1071. doi: 10.1097/00007890-199305000-00024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. McKeating J. A., Griffiths P. D., Grundy J. E. Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response? J Gen Virol. 1987 Mar;68(Pt 3):785–792. doi: 10.1099/0022-1317-68-3-785. [DOI] [PubMed] [Google Scholar]
  102. Mellencamp M. W., O'Brien P. C., Stevenson J. R. Pseudorabies virus-induced suppression of major histocompatibility complex class I antigen expression. J Virol. 1991 Jun;65(6):3365–3368. doi: 10.1128/jvi.65.6.3365-3368.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Melnick J. L., Adam E., DeBakey M. E. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990 Apr 25;263(16):2204–2207. [PubMed] [Google Scholar]
  104. Melnick J. L., Petrie B. L., Dreesman G. R., Burek J., McCollum C. H., DeBakey M. E. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983 Sep 17;2(8351):644–647. doi: 10.1016/s0140-6736(83)92529-1. [DOI] [PubMed] [Google Scholar]
  105. Myerson D., Hackman R. C., Nelson J. A., Ward D. C., McDougall J. K. Widespread presence of histologically occult cytomegalovirus. Hum Pathol. 1984 May;15(5):430–439. doi: 10.1016/s0046-8177(84)80076-3. [DOI] [PubMed] [Google Scholar]
  106. Neefjes J. J., Momburg F. Cell biology of antigen presentation. Curr Opin Immunol. 1993 Feb;5(1):27–34. doi: 10.1016/0952-7915(93)90077-6. [DOI] [PubMed] [Google Scholar]
  107. Neufeld D. S., Platzer M., Davies T. F. Reovirus induction of MHC class II antigen in rat thyroid cells. Endocrinology. 1989 Jan;124(1):543–545. doi: 10.1210/endo-124-1-543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Ohashi P. S., Oehen S., Aichele P., Pircher H., Odermatt B., Herrera P., Higuchi Y., Buerki K., Hengartner H., Zinkernagel R. M. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J Immunol. 1993 Jun 1;150(11):5185–5194. [PubMed] [Google Scholar]
  109. Ohlén C., Bejarano M. T., Grönberg A., Torsteinsdottir S., Franksson L., Ljunggren H. G., Klein E., Klein G., Kärre K. Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2. J Immunol. 1989 May 1;142(9):3336–3341. [PubMed] [Google Scholar]
  110. Oldstone M. B. Molecular anatomy of viral persistence. J Virol. 1991 Dec;65(12):6381–6386. doi: 10.1128/jvi.65.12.6381-6386.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Pak C. Y., Eun H. M., McArthur R. G., Yoon J. W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet. 1988 Jul 2;2(8601):1–4. doi: 10.1016/s0140-6736(88)92941-8. [DOI] [PubMed] [Google Scholar]
  112. Percivalle E., Revello M. G., Vago L., Morini F., Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest. 1993 Aug;92(2):663–670. doi: 10.1172/JCI116635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Petit A. J., Terpstra F. G., Miedema F. Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells. J Clin Invest. 1987 Jun;79(6):1883–1889. doi: 10.1172/JCI113032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Pugliese O., Viora M., Camponeschi B., Cordiali Fei P., Caprilli F., Chersi A., Evangelista M., Di Massimo A. M., Colizzi V. A gp120 HIV peptide with high similarity to HLA class II beta chains enhances PPD-specific and autoreactive T cell activation. Clin Exp Immunol. 1992 Nov;90(2):170–174. doi: 10.1111/j.1365-2249.1992.tb07923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Päbo S., Nilsson T., Peterson P. A. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9665–9669. doi: 10.1073/pnas.83.24.9665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Rager-Zisman B., Ju G., Rajan T. V., Bloom B. R. Decreased expression of H-2 antigens following acute measles virus infection. Cell Immunol. 1981 Apr;59(2):319–329. doi: 10.1016/0008-8749(81)90412-3. [DOI] [PubMed] [Google Scholar]
  117. Raulet D. H. Immunology. A sense of something missing. Nature. 1992 Jul 2;358(6381):21–22. doi: 10.1038/358021a0. [DOI] [PubMed] [Google Scholar]
  118. Rawle F. C., Tollefson A. E., Wold W. S., Gooding L. R. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J Immunol. 1989 Sep 15;143(6):2031–2037. [PubMed] [Google Scholar]
  119. Rinaldo C. R., Jr Immune suppression by herpesviruses. Annu Rev Med. 1990;41:331–338. doi: 10.1146/annurev.me.41.020190.001555. [DOI] [PubMed] [Google Scholar]
  120. Rose J. S., Grundy J. E. Beta 2 microglobulin on the envelope of urinary cytomegalovirus is not associated with host class I human leukocyte antigen alpha chain. J Gen Virol. 1992 Mar;73(Pt 3):507–512. doi: 10.1099/0022-1317-73-3-507. [DOI] [PubMed] [Google Scholar]
  121. Routes J. M. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. J Immunol. 1992 Oct 1;149(7):2372–2377. [PubMed] [Google Scholar]
  122. Rubin R. H. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA. 1989 Jun 23;261(24):3607–3609. [PubMed] [Google Scholar]
  123. Santomenna L. D., Colberg-Poley A. M. Induction of cellular hsp70 expression by human cytomegalovirus. J Virol. 1990 May;64(5):2033–2040. doi: 10.1128/jvi.64.5.2033-2040.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Sawada M., Suzumura A., Yoshida M., Marunouchi T. Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells. J Virol. 1990 Aug;64(8):4002–4006. doi: 10.1128/jvi.64.8.4002-4006.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Scheppler J. A., Nicholson J. K., Swan D. C., Ahmed-Ansari A., McDougal J. S. Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. J Immunol. 1989 Nov 1;143(9):2858–2866. [PubMed] [Google Scholar]
  126. Scholz M., Hamann A., Blaheta R. A., Auth M. K., Encke A., Markus B. H. Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum Immunol. 1992 Dec;35(4):230–238. doi: 10.1016/0198-8859(92)90004-7. [DOI] [PubMed] [Google Scholar]
  127. Sedmak D. D., Roberts W. H., Stephens R. E., Buesching W. J., Morgan L. A., Davis D. H., Waldman W. J. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression. Transplantation. 1990 Feb;49(2):458–462. doi: 10.1097/00007890-199002000-00043. [DOI] [PubMed] [Google Scholar]
  128. Shemesh J., Rotem-Yehudar R., Ehrlich R. Transcriptional and posttranscriptional regulation of class I major histocompatibility complex genes following transformation with human adenoviruses. J Virol. 1991 Oct;65(10):5544–5548. doi: 10.1128/jvi.65.10.5544-5548.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Span A. H., Mullers W., Miltenburg A. M., Bruggeman C. A. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology. 1991 Mar;72(3):355–360. [PMC free article] [PubMed] [Google Scholar]
  130. Span A. H., Van Boven C. P., Bruggeman C. A. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Eur J Clin Invest. 1989 Dec;19(6):542–548. doi: 10.1111/j.1365-2362.1989.tb00272.x. [DOI] [PubMed] [Google Scholar]
  131. Suzumura A., Lavi E., Weiss S. R., Silberberg D. H. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science. 1986 May 23;232(4753):991–993. doi: 10.1126/science.3010460. [DOI] [PubMed] [Google Scholar]
  132. Tanaka Y., Tevethia S. S. Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis. Virology. 1988 Aug;165(2):357–366. doi: 10.1016/0042-6822(88)90580-6. [DOI] [PubMed] [Google Scholar]
  133. Ting J. P., Baldwin A. S. Regulation of MHC gene expression. Curr Opin Immunol. 1993 Feb;5(1):8–16. doi: 10.1016/0952-7915(93)90074-3. [DOI] [PubMed] [Google Scholar]
  134. Torsteinsdottir S., Masucci M. G., Ehlin-Henriksson B., Brautbar C., Ben Bassat H., Klein G., Klein E. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5620–5624. doi: 10.1073/pnas.83.15.5620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Tysoe-Calnon V. A., Grundy J. E., Perkins S. J. Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences. Biochem J. 1991 Jul 15;277(Pt 2):359–369. doi: 10.1042/bj2770359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Upton C., Mossman K., McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 1992 Nov 20;258(5086):1369–1372. doi: 10.1126/science.1455233. [DOI] [PubMed] [Google Scholar]
  137. Waldman W. J., Adams P. W., Orosz C. G., Sedmak D. D. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation. 1992 Nov;54(5):887–896. doi: 10.1097/00007890-199211000-00024. [DOI] [PubMed] [Google Scholar]
  138. Waldman W. J., Roberts W. H., Davis D. H., Williams M. V., Sedmak D. D., Stephens R. E. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol. 1991;117(3-4):143–164. doi: 10.1007/BF01310761. [DOI] [PubMed] [Google Scholar]
  139. Wold W. S., Gooding L. R. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology. 1991 Sep;184(1):1–8. doi: 10.1016/0042-6822(91)90815-s. [DOI] [PubMed] [Google Scholar]
  140. Wykes M. N., Shellam G. R., McCluskey J., Kast W. M., Dallas P. B., Price P. Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection. J Virol. 1993 Jul;67(7):4182–4189. doi: 10.1128/jvi.67.7.4182-4189.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Yamashiroya H. M., Ghosh L., Yang R., Robertson A. L., Jr Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol. 1988 Jan;130(1):71–79. [PMC free article] [PubMed] [Google Scholar]
  142. Yamashita Y., Shimokata K., Mizuno S., Yamaguchi H., Nishiyama Y. Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virology. 1993 Apr;193(2):727–736. doi: 10.1006/viro.1993.1181. [DOI] [PubMed] [Google Scholar]
  143. Yamashita Y., Shimokata K., Nishiyama Y. On the association of human beta 2 microglobulin with cell culture-grown human cytomegalovirus (HCMV). Virology. 1992 Sep;190(1):449–453. doi: 10.1016/0042-6822(92)91232-j. [DOI] [PubMed] [Google Scholar]
  144. Young J. A. HIV and HLA similarity. Nature. 1988 May 19;333(6170):215–215. doi: 10.1038/333215c0. [DOI] [PubMed] [Google Scholar]
  145. Zhou D. X., Taraboulos A., Ou J. H., Yen T. S. Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol. 1990 Aug;64(8):4025–4028. doi: 10.1128/jvi.64.8.4025-4028.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. de la Barrera S., Fainboim L., Lugo S., Picchio G. R., Muchinik G. R., de Bracco M. M. Anti-class II antibodies in AIDS patients and AIDS-risk groups. Immunology. 1987 Dec;62(4):599–604. [PMC free article] [PubMed] [Google Scholar]
  147. del Val M., Hengel H., Häcker H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U. H. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med. 1992 Sep 1;176(3):729–738. doi: 10.1084/jem.176.3.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. van Dorp W. T., Jonges E., Bruggeman C. A., Daha M. R., van Es L. A., van Der Woude F. J. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation. 1989 Sep;48(3):469–472. doi: 10.1097/00007890-198909000-00024. [DOI] [PubMed] [Google Scholar]
  149. van Dorp W. T., van Wieringen P. A., Marselis-Jonges E., Bruggeman C. A., Daha M. R., van Es L. A., van der Woude F. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation. 1993 Jun;55(6):1367–1371. doi: 10.1097/00007890-199306000-00029. [DOI] [PubMed] [Google Scholar]
  150. van Es A., Baldwin W. M., Oljans P. J., Tanke H. J., Ploem J. S., van Es L. A. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation. 1984 Jan;37(1):65–69. doi: 10.1097/00007890-198401000-00018. [DOI] [PubMed] [Google Scholar]
  151. van den Berg A. P., van Son W. J., Janssen R. A., Brons N. H., Heyn A. A., Scholten-Sampson A., Postma S., van der Giessen M., Tegzess A. M., de Leij L. H. Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. J Infect Dis. 1992 Dec;166(6):1228–1235. doi: 10.1093/infdis/166.6.1228. [DOI] [PubMed] [Google Scholar]
  152. von Willebrand E., Pettersson E., Ahonen J., Häyry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation. 1986 Oct;42(4):364–367. doi: 10.1097/00007890-198610000-00006. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES